Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Maravai LifeSciences Holdings Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 05:15PM GMT
Release Date Price: $36.18 (+2.35%)
Michael Leonidovich Ryskin
BofA Securities, Research Division - Associate

All right. Thank you for joining us. We'll kick off our next session. My name is Mike Ryskin. I'm on the life science tools and diagnostics team here at BofA. I'm joined by the session by Juan Avendano and the team.

And joining us as well, we have Kevin Herde and Deb Hart from Maravai. So I think to begin, we're going to go through some slides, just sort of set the background a little bit, and then we'll hop into a fireside chat after that.

So Kevin, off to you.

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - VP & CFO

Great. Thanks, Michael. It's a pleasure to present Maravai to you. For those who don't know the story, we went to public in November of 2020 and just recently reported our first quarter results this Monday.

On Slide 2, just to start, we will talk about certain forward-looking statements and non-GAAP measures, primarily adjusted EBITDA and some disclosures related to that.

Then I'll move to Slide 3 and kind of just talk about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot